- Hopes are rising for a working vaccine as the world continues to battle with the deadly Covid-19
- Two projects in the UK and the US have reported promising results in their early experiments
- Experimental jabs are being developed by these teams and they both say the results are promising
As the world battles with the deadly Covid-19, two projects in the UK and the US have reported promising results in their early experiments, Daily Trust reports.
Teams from Oxford University and the American pharmaceutical company Moderna have been developing experiment jabs for months.
Briefly.co.za gathers that the teams are trying to protect millions of people from being infected with Covid-19 in the future.
Both teams have revealed that people in their studies are showing signs of immunity.
Oxford scientists said they are 80 per cent confident that they can have a jab available by September.
Researchers said antibodies and white blood cells called T cells are being developed by people that are given the Oxford vaccine.
The antibodies and white blood cells will help their bodies fight off the virus if they get infected.
According to experts at Moderna, based in Cambridge, Massachusetts, participants in their trial all successfully developed antibodies.
In other news, people around the world are feeling hopeful after Russia revealed good news in terms of a coronavirus vaccine.
Russia announced it completed human trials of the Covid-19 vaccine and the results looked promising.
South Africans flooded social media with their views and many prayed that the vaccine works amid rising number of cases in Mzansi.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!